1. MicroRNA 33A controls SREBP-2 and LXR dependent regulation of the LDL receptor pathway. (August 2022) Authors: Ramachandran, V.; Modder, M.; Zhang, L.; Krumm, C.; In Het Panhuis, W.; Schönke, M.; Lu, Y.-C.; Hla, T.; Lee, A.-H.; Rensen, P.; Tontonoz, P.; Kooijman, S.; Najafi-Shoushtari, H. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Concomitant glucose-dependent insulinotropic receptor (GIPR) and glucagon-like peptide-1 receptor (GLP1R) agonism stimulates TG-rich lipoprotein metabolism and attenuates atherosclerosis development. (August 2021) Authors: Modder, M.; Van Eenige, R.; Ying, Z.; Qu, H.; Coskun, T.; Kooijman, S.; Rensen, P.C.N. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A single day of high fat diet feeding induces lipid accumulation and insulin resistance in brown adipose tissue in mice. (December 2020) Authors: Modder, M.; Kuipers, E.N.; Held, N.M.; Het Panhuis, W. In; Ruppert, P.M.M.; Kersten, S.; Kooijman, S.; Guisas, B.; Houtkooper, R.; Rensen, P.; Boon, M. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗